» Articles » PMID: 12147202

Interleukin-1--a Major Pleiotropic Cytokine in Tumor-host Interactions

Overview
Specialty Oncology
Date 2002 Jul 31
PMID 12147202
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin-1 (IL-1) represents a family of two agonistic proteins, IL-1alpha and IL-1beta, that are pleiotropic and affect hemopoiesis, inflammation, and immunity. In the context of the producing cell, IL-1beta is solely active in its secreted form, whereas IL-1alpha is active as an intracellular precursor, as a membrane-associated cytokine and to a lesser extent as a secreted molecule. IL-1 is abundant at tumor sites, where it may not only affect the growth and invasiveness of malignant cells, but where it may also induce antitumor immunity. Here we review the effects of microenvironmental and tumor cell-associated IL-1 on malignant processes, in experimental tumor models and in cancer patients.

Citing Articles

Oxidative Stress and Redox-Dependent Pathways in Cholangiocarcinoma.

Caligiuri A, Becatti M, Porro N, Borghi S, Marra F, Pastore M Antioxidants (Basel). 2024; 13(1).

PMID: 38247453 PMC: 10812651. DOI: 10.3390/antiox13010028.


Interleukin-1 receptor antagonist: a promising cytokine against human squamous cell carcinomas.

Ding Y, Yi J, Wang J, Sun Z Heliyon. 2023; 9(4):e14960.

PMID: 37025835 PMC: 10070157. DOI: 10.1016/j.heliyon.2023.e14960.


Molecular mechanism of cerebral edema improvement via IL-1RA released from the stroke-unaffected hindlimb by treadmill exercise after cerebral infarction in rats.

Gono R, Sugimoto K, Yang C, Murata Y, Nomura R, Shirazaki M J Cereb Blood Flow Metab. 2023; 43(5):812-827.

PMID: 36651110 PMC: 10108195. DOI: 10.1177/0271678X231151569.


Revisiting the therapeutic potential of gingerols against different pharmacological activities.

Sharma S, Shukla M, Sharma K, Tirath , Kumar L, Momo H Anal J Naunyn Schmiedebergs Arch Pharmacol. 2022; 396(4):633-647.

PMID: 36585999 PMC: 9803890. DOI: 10.1007/s00210-022-02372-7.


Mutant C/EBPα p30 alleviates immunosuppression of CD8 T cells by inhibiting autophagy-associated secretion of IL-1β in AML.

Wang J, Xu J, Zhang X, Huang Z, Liu L, Zhang L Cell Prolif. 2022; 55(12):e13331.

PMID: 36124714 PMC: 9715362. DOI: 10.1111/cpr.13331.